Hasil Pencarian  ::  Simpan CSV :: Kembali

Abstrak :
Penelitian ini bertujuan untuk membandingkan efektivitas biaya penggunaan sediaan D10-CaGluconas dan D5-1/4NS. Disain penelitian adalah kohort retrospektif pada pasien neonatus penderita Respiratory Distress Syndrome (RDS) dengan berat badan normal di RSU Kambang Jambi. Penelitian dilaksanakan pada kurun waktu September 2014-Juni 2015. Subyek penelitian terbagi dalam dua kelompok yaitu yang menggunakan D10-CaGluconas 40 pasien dan D5-1/4NS 43 pasien. Efektivitas dinilai dari perubahan hasil pemeriksaan fisik pasien yaitu rata - rata berat badan (28,48 gram/hari), kadar glukosa darah sewaktu (26,73 mg/dL), respiratory rate (-12,35 x/menit), frekuensi nadi (-10,98 x/menit), dan temperatur tubuh (0,013oC) pada sediaan D10-CaGluconas. Rata - rata efektivitas berat badan (23,49 gram/hari), kadar glukosa darah sewaktu (26,42 mg/dL), respiratory rate (-7,77 x/menit), frekuensi nadi (-8,07 x/menit), dan temperatur tubuh (0,012oC) pada sediaan D5-1/4NS. Rata - rata biaya langsung medis sediaan D10-CaGluconas adalah Rp. 458.290 dan D5-1/4NS adalah Rp. 408.347. Nilai ACER total biaya langsung medis sediaan D10-CaGluconas adalah Rp. 35.207.467, nilai ACER sediaan D5-1/4NS adalah Rp. 33.958.602. Nilai ICER biaya langsung medis sediaan D5-1/4NS terhadap sediaan D10-Ca.gluconas tiap efektivitas kenaikan berat badan adalah Rp. 10.009, kadar glukosa darah sewaktu adalah Rp. 161.107, respiratory rate adalah Rp. 10.905, frekuensi nadi adalah Rp. 17.163 dan temperatur tubuh adalah Rp. 49.943.000. Nilai rata - rata ICER total biaya langsung medis sediaan B terhadap sediaan A adalah Rp. 10.017.210. Sediaan parenteral nutrisi D10-CaGluconas lebih costeffective dibandingkan dengan sediaan D5-1/4NS. ......This study aimed to compare the cost-effectiveness of the use of D10-CaGluconate and D5-1/4NS preparations. The design was a retrospective cohort study in neonatal Respiratory Distress Syndrome (RDS ) patients with normal weights in RSU Kambang Jambi. The research was conducted during the period September 2014 to June 2015. The research subjects were divided into two group, the use of D10-CaGluconate was 40 patients and D5-1/4NS was 43 patients . Effectiveness were seen from the changes of the patients physical examination results, on averages weights (28.48 grams/day), blood glucose levels (26.73 mg/dL), respiratory rates (-12.35 x/min), pulse rates (-10.98x/min), and the body temperature (0.013°C ) in D10-CaGluconate preparations. The average effectiveness of weight (23.49 grams/day), blood glucose levels (26.42 mg/dL), respiratory rates (-7.77 x/min ), pulse rates (-8.07 x/min), and the body temperatures (0.012°C) in D5-1/4NS preparations. The Average direct medical costs of D10- CaGluconate and D5-1/4NS were Rp. 458,290 and Rp. 408,347. The ACER values of total direct medical costs of D10-CaGluconate preparation were Rp. 35,207,467, while D5-1/4NS was Rp. 33,958,602. The ICER values of the direct medical costs of the D5-1/4NS preparations of D10-CaGluconas on each effectiveness of weights were Rp. 10,009, blood glucose levels were Rp. 161,107, respiratory rates were Rp. 10,905, pulse rates were Rp. 17,163, and the body temperature was Rp. 49,943,000. The averages ICER values of the direct medical costs of the D5-1/4NS preparations of D10-CaGluconate were Rp. 10,017,210. The parenteral nutrition preparations of D10-CaGluconate are more cost-effective compared to the D5-1/4NS.

Abstrak :
ABSTRAK
Tesis ini membahas kemampuan mahasiswa Fakultas Psikologi UAngka penemuan kasus menurut Global tuberculosis Report 2016 sebesar 77 dan dikawasan Asia Tenggara sebesar 46,5 . Sedangkan di Indonesia mengalami titik stagnan dalam 5tahun terakhir di kisaran 32 - 33 kasus. Angka penemuan kasus TBC di Kota Depok tahun2016 baru tercapai 58 dari target cakupan. Sedangkan di Kota Bekasi, cakupannya sebesar62 . Sejak tahun 2014 dengan menggunakan strategi PPM Public Private Mix di Kota Depokmelibatkan fasyankes Fasilitas Pelayanan Kesehatan swasta dalam penanganan TBCmenggunakan metode DOTS Directly Observed Treatment Shortcourse. Saat ini, dari 4 RSswasta yang sudah bekerja sama menjangkau 18,7 kasus TBC di seluruh Kota Depok.Penelitian ini bertujuan untuk mengetahui efektivitas biaya penerapan strategi DOTS di RumahSakit swasta Kota Depok. Penelitian ini merupakan penelitian evaluasi ekonomi dengan denganmetode kohort retrospektif. Penelitian ini akan dilakukan pada bulan Oktober ndash; April 2018dengan melakukan study comparative antara 3 alternatif Cost Effectiveness Analysis , yaituPuskesmas yang menggunakan DOTS, RS DOTS dan RS Tanpa DOTS. Peneliti melakukanpenghitungan microcosting dari perspektif societal/masyarakat dengan menghitung biaya yangdikeluarkan oleh pasien dan provider pelayanan kesehatan. Output yang dipakai untuk mengukurpenanganan TBC adalah angka pengobatan lengkap Success Rate . Estimasi biaya berdasarkantarif Rumah Sakit, harga pasar, serta wawancara dari petugas RS.Hasil penelitian dari 36 sampel per kelompok menunjukkan bahwa Success Rate dipuskesmas 86,1 , RS dengan DOTS sebesar 77.78 sedangkan yang non DOTS sebesar 63.89 . Penambahan biaya provider di puskesmas dan RS DOTS meningkatkan success rate. Biayasocietal penatalaksanaan TBC di puskesmas 42 dari biaya di RS swasta. Dari perhitunganACER Average Cost Effectiveness Ratio didapatkan bahwa RS yang melaksanakan strategiDOTS lebih cost effective, dengan nilai ACER di Puskesmas adalah Rp 1.948.284, RS DOTS Rp3.989.576 dan RS tanpa DOTS sebesar Rp 5.390.323. Untuk menaikkan 1 angka kesuksesanpengobatan membutuhkan biaya Rp 10.084.572 dengan melakukan intervensi program DOTS keRS Swasta. Analisis bivariat menyatakan bahwa terdapat perbedaan bermakna efektivitas biayaperspektif societal pada pengobatan TBC di puskesmas, RS dengan DOTS, dan RS tanpa DOTS .Keywords : Cost effectiveness analysis, DOTS, Fasyankes swasta, Success Rate, ACER, ICER

---

ABSTRACT
According to Global Tuberculosis Report 2016, the number of TB cases 77 andSoutheast Asia cases 46.5. While Indonesia was at a stagnant point in the last 5 years in therange 32 33 of cases. Case Detection Rate 2016 at Depok City only reached 58 of targetcoverage. While at Bekasi, coverage of 62. Since the year 2014 by using strategies of PPM Public Private Mix in the Depok City involves private health service facility to handling TBusing DOTS Directly Observed Treatment Shortcourse . Currently, partnership between DepokHealth District Office with 4 private hospitals can increase 18.7 of TB cases. The aims of thisstudy is to determine cost effectiveness of DOTS strategy implementation in Private Hospital. This research is a study of the economic evaluation with method a retrospective cohortstudy. This research will be conducted in October ndash April 2018 by doing a comparative studybetween 3 alternatives Cost Effectiveness Analysis , i.e. Public Health Care PHC Puskesmas,DOTS and Non DOTS Private Hospitals. Researchers did a microcosting from the perspective ofsocietal by calculating the costs incurred by the patient and health care provider. Outputmeasured by the number of complete treatment Success Rate . Cost estimation based onHospital rates, market prices, and interviews of the officers of hospital.From 36 samples per group shows that the Success Rate at PHCis 86.1 DOTS hospitalof 77.78 and non DOTS hospital of 63.89 . The addition cost providers PHC and DOTShospital increase success rate. The cost of TB treatment in PHC 42 of costs in a privatehospital. ACER Average Cost Effectiveness Ratio is obtained that the hospital which carry outthe strategy of DOTS is more cost effective. ACER in PHC is Rp 1,948,284, DOTS Hospital Rp3,989,576 and Non DOTS Hospital is Rp 5,390,323. To increase 1 success rate of TBtreatment costs Rp 10,084,572 with intervention DOTS programs into a private hospital. Bivariatanalysis stated that cost effectiveness societal perspectives on TB treatment between PHC, DOTS hospital and Non DOTS hospital has a significant difference.Keywords Cost effectiveness analysis, DOTS, Fasyankes swasta, Success Rate, ACER, ICER